I agree that this site is using cookies. You can find further informations here.
X
Klinghammer, K.
31  results:
Search for persons X
?
1

155P BNT113 + pembrolizumab as first-line treatment in pati..:

Klinghammer, K. ; Saba, N.F. ; Castelluci, E....
Immuno-Oncology and Technology.  16 (2022)  - p. 100267 , 2022
Link: https://doi.org/10.1016/..
 
?
2

A randomized phase II study comparing the efficacy and safe..:

Klinghammer, K. ; Fayette, J. ; Kawecki, A....
ESMO Open.  6 (2021)  5 - p. 100242 , 2021
Link: https://doi.org/10.1016/..
 
?
3

Cetuximab, fluorouracil and cisplatin with or without docet..:

Klinghammer, K. ; Gauler, T. ; Dietz, A....
European Journal of Cancer.  122 (2019)  - p. 53-60 , 2019
Link: https://doi.org/10.1016/..
 
?
4

First-in-man dose escalation and pharmacokinetic study of C..:

Keilholz, U. ; Rohde, L. ; Mehlitz, P....
European Journal of Cancer.  80 (2017)  - p. 14-25 , 2017
Link: https://doi.org/10.1016/..
 
?
5

Molecular subtypes of head and neck cancer predict response..:

Klinghammer, K. ; Otto, R. ; Raguse, J.D....
European Journal of Cancer.  69 (2016)  - p. S53 , 2016
Link: https://doi.org/10.1016/..
 
?
6

Contribution of human papilloma virus to the incidence of s..:

Tinhofer, I. ; Jöhrens, K. ; Keilholz, U....
European Journal of Cancer.  51 (2015)  4 - p. 514-521 , 2015
Link: https://doi.org/10.1016/..
 
?
7

10 mTOR inhibition with everolimus – a novel treatment opti..:

Klinghammer, K. ; Raguse, J.D. ; Plath, T....
European Journal of Cancer.  50 (2014)  - p. 10 , 2014
Link: https://doi.org/10.1016/..
 
?
8

614 First-in-man Dose Escalation and Pharmacokinetic Study ..:

Keilholz, U. ; Knoedler, M. ; Schmittel, A....
European Journal of Cancer.  48 (2012)  - p. 189 , 2012
Link: https://doi.org/10.1016/..
 
?
9

1024 EGFR single nucleotid polymorphism R521K is a predicto..:

Klinghammer, K. ; Knödler, M. ; Budach, V...
European Journal of Cancer Supplements.  7 (2009)  2 - p. 94 , 2009
Link: https://doi.org/10.1016/..
 
?
10

Safety and preliminary activity results of the GATTO study,..:

Ochsenreither, S. ; Fiedler, W.M. ; Conte, G.D....
ESMO Open.  7 (2022)  2 - p. 100447 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Erratum to 'Safety and preliminary activity results of the ..:

Ochsenreither, S. ; Fiedler, W.M. ; Del Conte, G....
ESMO Open.  7 (2022)  4 - p. 100549 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Results from the primary analysis of a 30 patient extension..:

Macchini, M. ; Garralda, E. ; Fiedler, W....
European Journal of Cancer.  138 (2020)  - p. S5-S6 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Molecular subtyping of head and neck cancer - Clinical appl..:

Stögbauer, F ; Otto, R ; Jöhrens, K...
http://edoc.mdc-berlin.de/24026/1/24026oa.pdf.  , 2024
Link: http://edoc.mdc-berlin.d..
 
?
14

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-..:

Rieke, D.T ; Schröder, S ; Schafhausen, P...
http://edoc.mdc-berlin.de/23548/1/23548oa.pdf.  , 2023
Link: http://edoc.mdc-berlin.d..
 
?
15

Treatment Stratification in First-Line Recurrent or Metasta..:

Klinghammer K ; Lorini L ; Nevens D...
info:eu-repo/semantics/altIdentifier/pmid/35155222.  , 2022
Link: http://hdl.handle.net/11..
 
1-15